Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X)

European Respiratory Journal

Volumn 9, Issue 10, 1996, Pages 2002-2006

  Delobbe, A ^a   Durieu, J ^a   Duhamel, A ^b   Wallaert, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Faculté de Médecine Pôle Recherché   (France)

Author keywords

histiocytosis X; interstitial lung disease; Langerhans' cell granulomatosis; lung; survival

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETOPOSIDE; MITOGUAZONE; NAVELBINE; VINBLASTINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HISTIOCYTOSIS X; HUMAN; LUNG BIOPSY; LUNG FUNCTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SMOKING; STATISTICS;

EID: 0029761543     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09102002     Document Type: Article

References (35)

1. Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease clinical, roentgenographic, and physiologic correlations in 502 patients. Ann Thorac Surg 1980; 30: 411-426.
2. Basset F, Corrin B, Spencer H, et al. Pulmonary histiocytosis X. Am Rev Respir Dis 1978; 118: 811-820.
3. Marcy TW, Reynolds HY. Pulmonary histiocytosis X. Lung 1985; 163: 129-150.
4. Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans' cell histiocytosis with malignant neoplasms. Cancer 1993; 71: 865-873.
5. Hance AJ, Cadranel J, Soler P, Basser F. Pulmonary and extrapulmonary Langerhans' cell granulomatosis (histiocytosis X). Semin Respir Med 1988; 9: 349-368.
6. Nezelof C, Frileux H, Cronier-Sachot J. Disseminated histiocytosis X: analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979; 44: 1824-1838.
7. Power MA, Askin FB, Creson DH. Pulmonary eosinophilic granuloma: 25 year follow-up. Am Rev Respir Dis 1984; 129: 503-507.
8. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Medicine 1981; 60: 385.
9. Sadoun D, Valeyre D, Clerici C, Loiseau P, Battesti JP, Georges R. Clinical follow-up study in 33 patients with Langerhans' cell granulomatosis. Am Rev Respir Dis 1990; 141: A319.
10. Askin FB. Pulmonary eosinophilic granuloma. Am Rev Respir Dis 1984; 29: 503-507.
11. Lewis JG. Eosinophilic granuloma and its variants with special reference to lung involvement: a report of 12 patients. QJ Med 1964; 131: 337.
12. Schönfeld N, Frank W, Wenig S, et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993; 60: 38-44.
13. William G, Hocking MD, Swanson M. Multifocal eosinophilic granuloma. Cancer 1986; 58: 840-842.
14. Soler P, Kambouchner M, Valeyre D, Habce AJ. Pulmonary Langerhans' cell granulomatosis (histiocytocis X). Annu Rev Med 1992; 43: 105-115.
15. Webber D, Tron V, Askin F, Churg A. S-100 staining in the diagnosis of eosinphilic granuloma of lung. Am J Clin Pathol 1985; 84: 447-453.
16. Chollet S, Soler P, Dournovo P, Richard MS, Ferrans VJ, Basset F. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans' cells in bronchoalveolar lavage fluid. Am J Pathol 1984; 115: 225-232.
17. Auerswald U, Barth J, Magnussen H, Value of CD1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1991; 169: 305-309.
18. Basset F, Soler P, Jaurand MC, Bignon J. Ultrastructural examination of bronchoalveolar lavage for diagnosis of pulmonary histiocytosis X. Thorax 1977; 32: 303-306.
19. Quanjer Ph. Standardized lung function testing. Report working patty, standardization of lung function tests. Bull Eur Physiopathol Respir 1983; 19 (Suppl. 5): 1-95.
20. International Labour Organisation. International classification of radiographs of pneumoconiosis: guidelines for the use of International Labour Organisation (ILO). Geneva, International Labour Office, 1980.
21. Kaplan EL, Meier P. Nonparametic estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
22. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). JR Stat Soc A 1972; 135: 185-206.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
24. Cox DR. Regression models and life tables. JR Stat Soc Br 1972; 34: 187-220.
25. Cox DR, Oakes D. Analysis of survival data. London, Chapman and Hall, 1984.
26. Kalbfleisch JO, Prentice RL. The statistical analysis of failure time data. New York, J. Wiley, 1980.
27. Furnival GM, Wilson RW. Regressions by leaps and bounds. Technometrics 1974; 16: 499-511.
28. Lacronique J, Roth C, Battesti JP, Basset F, Chretien J. Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 1982; 37: 104-119.
29. Brauner MW, Grenier P, Montasser MM, Mompoint D, Lenoir S. Pulmonary histiocytosis X: evaluation with high resolution CT. Radiology 1989; 172: 255-258.
30. Kulwiec E, Lynch DA, Aguayo SM, Schwarz MI, King TE Jr. Imaging of pulmonary histiocytosis X. Radiographics 1992; 12: 515-526.
31. Firedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981; 60: 385-396.
32. Travis WD, Borok Z, Roum JH, Fenerstein I, Ferrans VJ, Crystal RG. Pulmonary Langerhans' cell granulomatosis (histiocytosis X): a clinicopathologic study in 48 cases. Am J Surg Pathol 1993; 17: 971-986.
33. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 450-454.
34. Ladisch S, Gadner H. Treatment of Langerhans' cell histiocytosis: evolution and current approaches. Br J Cancer 1994; 70 (Suppl. XXIII): S41-S46.
35. Von Essen S, West W, Sitorius M, Rennard SI. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990; 98: 765-767.